FOFF ERIN PENNOCK (Chief Medical Officer) sold 12.5% of their position (50.28K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.43M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Voting Common Stock
Shares
−9.18K
Price / share
$27.50
Trade value
$252.45K
% of position
Voting Common Stock
Shares
−5.46K
Price / share
$28.37
Trade value
$154.90K
% of position
Voting Common Stock
Shares
−312.00
Price / share
$29.56
Trade value
$9.22K
% of position
Voting Common Stock
Shares
−700.00
Price / share
$30.08
Trade value
$21.06K
% of position
Voting Common Stock
Shares
−9.64K
Price / share
$28.12
Trade value
$271.22K
% of position
Voting Common Stock
Shares
−931.00
Price / share
$29.00
Trade value
$27K
% of position
Voting Common Stock
Shares
−8.15K
Price / share
$28.04
Trade value
$228.58K
% of position
Voting Common Stock
Shares
−15.90K
Price / share
$29.13
Trade value
$463.17K
% of position
Net shares
−50.28K
Net value
-$1.43M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −9.18K | $27.50 | $252.45K | 2.3% | 400.78K | 391.60K |
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −5.46K | $28.37 | $154.90K | 1.4% | 391.60K | 386.14K |
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −312.00 | $29.56 | $9.22K | 0.1% | 386.14K | 385.82K |
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −700.00 | $30.08 | $21.06K | 0.2% | 385.82K | 385.13K |
| Voting Common Stock Direct | 5/5/2026 | S · Sale | −9.64K | $28.12 | $271.22K | 2.5% | 385.13K | 375.48K |
| Voting Common Stock Direct | 5/5/2026 | S · Sale | −931.00 | $29.00 | $27K | 0.2% | 375.48K | 374.55K |
| Voting Common Stock Direct | 5/6/2026 | S · Sale | −8.15K | $28.04 | $228.58K | 2.2% | 374.55K | 366.40K |
| Voting Common Stock Direct | 5/6/2026 | S · Sale | −15.90K | $29.13 | $463.17K | 4.3% | 366.40K | 350.50K |
| Total | −50.28K | -$1.43M | ||||||